- Breast Cancer
- Cancer Control
- Chemotherapy
- Diagnostics and Screening
- Gastrointestinal Cancers
- Genitourinary Cancers
- Geriatric Oncology
- Gynecological Oncology
- Head, Neck and Thyroid Cancers
- Hematology
- Hematological Malignancies
- Imaging
- Lung Cancer
- Neurological Cancers
- Pediatric Oncology
- Radiotherapy
- Sarcomas and Melanomas
- Supportive Oncology
Specialties
Fri, 2012-06-01
Thu, 2012-06-14
Thu, 2012-06-28
Latest Testimonial
"Very well done and exciting. Congratulations."
Professor of Medicine and Director
Emili Montserrat
Institute of Hematology and Oncology at the Hospital Clinic of Barcelona
Lymphoma
- Follicular Lymphoma Treatment
- Rearrangements in Lymphoma
- Granular Lymphocytic Proliferations
- Poor Prognosis in the Rituximab Era
Follicular Lymphoma Treatment
Current First-line and Salvage Treatment Strategies in Patients with Advanced-stage Follicular Lymphoma
Frank Heinzelmann, Michael Bamberg, Martin Weinmann
European Oncology, 2010;6(2):58-63
Rearrangements in Lymphoma
Oncogenic Anaplastic Lymphoma Kinase Rearrangements in Lymphoma
Katrien Van Roosbroeck, Iwona Włodarska
European Haematology, 2009;3(1):50-6
Granular Lymphocytic Proliferations
The Spectrum of T-cell and Natural Killer – Large Granular Lymphocytic Proliferations
Estella Matutes
European Haematology, 2010;4:65-9
Poor Prognosis in the Rituximab Era
The Treatment of Diffuse Large B-cell Lymphoma with Poor Prognosis in the Rituximab Era – State of the Art and Future Perspectives
Umberto Vitolo, Annalisa Chiappella, Chiara Frairia, Barbara Botto
European Haematology, 2010;4:75-9











